Page last updated: 2024-10-24

chelerythrine and Brugada Syndrome

chelerythrine has been researched along with Brugada Syndrome in 2 studies

chelerythrine : A benzophenanthridine alkaloid isolated from the root of Zanthoxylum simulans, Chelidonium majus L., and other Papaveraceae.

Brugada Syndrome: An autosomal dominant defect of cardiac conduction that is characterized by an abnormal ST-segment in leads V1-V3 on the ELECTROCARDIOGRAM resembling a right BUNDLE-BRANCH BLOCK; high risk of VENTRICULAR TACHYCARDIA; or VENTRICULAR FIBRILLATION; SYNCOPAL EPISODE; and possible sudden death. This syndrome is linked to mutations of gene encoding the cardiac SODIUM CHANNEL alpha subunit.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, M1
Sanyal, S1
Gao, G1
Gurung, IS1
Zhu, X1
Gaconnet, G1
Kerchner, LJ1
Shang, LL1
Huang, CL1
Grace, A1
London, B1
Dudley, SC1
Chahine, M1

Other Studies

2 other studies available for chelerythrine and Brugada Syndrome

ArticleYear
Cardiac Na+ current regulation by pyridine nucleotides.
    Circulation research, 2009, Oct-09, Volume: 105, Issue:8

    Topics: Animals; Antineoplastic Agents; Benzophenanthridines; Brugada Syndrome; Cell Line; Cyclic AMP-Depend

2009
Cardiac metabolic state and Brugada syndrome: a link revealed.
    Circulation research, 2009, Oct-09, Volume: 105, Issue:8

    Topics: Animals; Antineoplastic Agents; Benzophenanthridines; Brugada Syndrome; Cell Line; Cyclic AMP-Depend

2009